Douglas Lane & Associates’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14M | Buy |
44,349
+43,404
| +4,593% | +$13.7M | 0.19% | 111 |
|
|
2026
Q1 | $311K | Buy |
945
+28
| +3% | +$10.1K | ﹤0.01% | 208 |
|
|
2025
Q4 | $322K | Sell |
917
-81
| -8% | -$29.5K | ﹤0.01% | 200 |
|
|
2025
Q3 | $369K | Sell |
998
-163
| -14% | -$63K | 0.01% | 195 |
|
|
2025
Q2 | $459K | Sell |
1,161
-28
| -2% | -$10.5K | 0.01% | 181 |
|
|
2025
Q1 | $443K | Sell |
1,189
-25
| -2% | -$9.51K | 0.01% | 189 |
|
|
2024
Q4 | $437K | Hold |
1,214
| – | – | 0.01% | 188 |
|
|
2024
Q3 | $439K | Buy |
1,214
+350
| +41% | +$121K | 0.01% | 190 |
|
|
2024
Q2 | $294K | Buy |
864
+292
| +51% | +$98.9K | ﹤0.01% | 207 |
|
|
2024
Q1 | $205K | Sell |
572
-1,135
| -66% | -$382K | ﹤0.01% | 234 |
|
|
2023
Q4 | $511K | Sell |
1,707
-178
| -9% | -$50K | 0.01% | 175 |
|
|
2023
Q3 | $515K | Buy |
1,885
+74
| +4% | +$21.2K | 0.01% | 169 |
|
|
2023
Q2 | $553K | Sell |
1,811
-180
| -9% | -$52K | 0.01% | 172 |
|
|
2023
Q1 | $568K | Sell |
1,991
-130
| -6% | -$34.5K | 0.01% | 170 |
|
|
2022
Q4 | $519K | Sell |
2,121
-29
| -1% | -$6.58K | 0.01% | 170 |
|
|
2022
Q3 | $435K | Buy |
2,150
+20
| +0.9% | +$4.21K | 0.01% | 179 |
|
|
2022
Q2 | $424K | Hold |
2,130
| – | – | 0.01% | 184 |
|
|
2022
Q1 | $569K | Sell |
2,130
-20
| -0.9% | -$5.18K | 0.01% | 172 |
|
|
2021
Q4 | $575K | Buy |
2,150
+98
| +5% | +$25.7K | 0.01% | 173 |
|
|
2021
Q3 | $541K | Buy |
2,052
+34
| +2% | +$9.09K | 0.01% | 168 |
|
|
2021
Q2 | $524K | Hold |
2,018
| – | – | 0.01% | 167 |
|
|
2021
Q1 | $492K | Buy |
2,018
+6
| +0.3% | +$1.44K | 0.01% | 161 |
|
|
2020
Q4 | $493K | Sell |
2,012
-65
| -3% | -$14.7K | 0.01% | 160 |
|
|
2020
Q3 | $433K | Hold |
2,077
| – | – | 0.01% | 162 |
|
|
2020
Q2 | $374K | Buy |
2,077
+165
| +9% | +$30.4K | 0.01% | 169 |
|
|
2020
Q1 | $318K | Sell |
1,912
-48
| -2% | -$9.38K | 0.01% | 172 |
|
|
2019
Q4 | $411K | Buy |
1,960
+220
| +13% | +$45.7K | 0.01% | 173 |
|
|
2019
Q3 | $376K | Sell |
1,740
-50
| -3% | -$10.7K | 0.01% | 176 |
|
|
2019
Q2 | $368K | Hold |
1,790
| – | – | 0.01% | 184 |
|
|
2019
Q1 | $354K | Sell |
1,790
-41
| -2% | -$7.38K | 0.01% | 182 |
|
|
2018
Q4 | $287K | Buy |
1,831
+100
| +6% | +$16.7K | 0.01% | 185 |
|
|
2018
Q3 | $308K | Buy |
1,731
+111
| +7% | +$18.9K | 0.01% | 181 |
|
|
2018
Q2 | $274K | Sell |
1,620
-150
| -8% | -$25.2K | 0.01% | 179 |
|
|
2018
Q1 | $285K | Sell |
1,770
-100
| -5% | -$16.1K | 0.01% | 181 |
|
|
2017
Q4 | $290K | Buy |
1,870
+30
| +2% | +$4.58K | 0.01% | 178 |
|
|
2017
Q3 | $261K | Sell |
1,840
-25
| -1% | -$3.58K | 0.01% | 189 |
|
|
2017
Q2 | $259K | Sell |
1,865
-235
| -11% | -$32.2K | 0.01% | 186 |
|
|
2017
Q1 | $276K | Sell |
2,100
-528
| -20% | -$66.7K | 0.01% | 190 |
|
|
2016
Q4 | $315K | Sell |
2,628
-292
| -10% | -$33.6K | 0.01% | 188 |
|
|
2016
Q3 | $340K | Sell |
2,920
-25
| -0.8% | -$2.91K | 0.01% | 186 |
|
|
2016
Q2 | $353K | Buy |
2,945
+20
| +0.7% | +$2.24K | 0.01% | 188 |
|
|
2016
Q1 | $314K | Buy |
+2,925
| New | +$288K | 0.01% | 191 |
|
Other funds holding SYK
GT
ATO
FAM
AAIS
RG
BTW
DC
JIC
Douglas Lane & Associates's SYK Position: Q2 2026 in Review
Douglas Lane & Associates increased its Stryker (SYK) stake by 4,593% in Q2 2026, buying an estimated $13.7M and bringing the position to 44,349 shares worth $14M. The position accounts for 0.19% of the portfolio, ranked #111.
Douglas Lane & Associates first reported a position in SYK in Q1 2016 and has held it in 42 quarters since. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.
- Douglas Lane & Associates held 44,349 shares of Stryker worth $14M as of Q2 2026.
- Douglas Lane & Associates bought 43,404 Stryker shares in Q2 2026, an estimated $13.7M.
- Stryker made up 0.19% of Douglas Lane & Associates's portfolio in Q2 2026, its #111 holding.
- Douglas Lane & Associates first reported a position in Stryker in Q1 2016 and has held it in 42 quarters since.
- 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.
Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.